L-Carnitine L-Tartrate Inhibits Gestational Diabetes
|L-Carnitine L-Tartrate Inhibits Gestational Diabetes||Darrell Miller||01/24/06|
January 24, 2006 05:15 PM
Author: Darrell Miller (firstname.lastname@example.org)
Subject: L-Carnitine L-Tartrate Inhibits Gestational Diabetes
Vienna, Austria—Intake of L-carnitine L-tartrate during pregnancy may thwart a sequence of reactions leading to gestational diabetes, according to a study published in Chemical Monthly (136, 8:1523-1533), 2005) (www.springerlink.com).
Scientists from the University of Vienna noted deficiency of carnitine in pregnant women from the 12th week of gestation through delivery leads to down-regulation of expression of certain enzymes involved in fatty acid metabolism; loMRNA levels of these enzymes promotes an increase in free fatty acid levels conducive to insulin resistance. The researchers found supplementation with L-carnitine L-tartrate (as L-Carnipure, from Lonza) increased relative mRNA levels of these enzymes in pregnant women.
In a release on the findings, Lonza (www.lonza.com) noted there appears to be increasing evidence that L-carnitine may play an important role during pregnancy, particularly in women following a meat-reduced or vegetarian diet.